Export 793 results:
Author Title Type [ Year(Desc)]
Filters: Keyword is Humans  [Clear All Filters]
M. Pacheco Pachado, Casas, A. I., Elbatreek, M. H., Nogales, C., Guney, E., Espay, A. J., and Schmidt, H. H. H. W., Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes., J Alzheimers Dis, vol. 96, no. 1, pp. 47-56, 2023.
S. Patel, Wei, J., Shi, Z., Rifkin, A. S., S Zheng, L., Gelfman, E., Duggan, D., Helfand, B. T., Hulick, P. J., and Xu, J., Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers., J Alzheimers Dis, vol. 94, no. 2, pp. 483-489, 2023.
K. Surya, Manickam, N., Jayachandran, K. Swaminatha, Kandasamy, M., and Anusuyadevi, M., Resveratrol Mediated Regulation of Hippocampal Neuroregenerative Plasticity via SIRT1 Pathway in Synergy with Wnt Signaling: Neurotherapeutic Implications to Mitigate Memory Loss in Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S125-S140, 2023.
B. Su Mee Hui, Zhi, L. Rui, Retinasamy, T., Arulsamy, A., Law, C. Shing Wei, Shaikh, M. Farooq, and Yeong, K. Yoon, The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review., J Alzheimers Dis, vol. 94, no. s1, pp. S45-S66, 2023.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits., J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
C. Wu, Ma, Y. - H., Hu, H., Zhao, B., and Tan, L., Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study., J Alzheimers Dis, vol. 92, no. 1, pp. 311-322, 2023.
K. Pushpa Tryphena, Anuradha, U., Kumar, R., Rajan, S., Srivastava, S., Singh, S. Bala, and Khatri, D. Kumar, Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S187-S202, 2023.
A. Loughman, Adler, C. J., and Macpherson, H., Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?, J Alzheimers Dis, vol. 92, no. 4, pp. 1111-1129, 2023.
S. Chand Basha, Ramaiah, M. Janaki, and Kosagisharaf, J. Rao, Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S319-S333, 2023.
H. Shinagawa, Ohuchi, K., Goto, Y., Hashimoto, K., Kijima, H., Maekawa, S., Kurita, H., and Inden, M., Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 96, no. 3, pp. 1011-1017, 2023.
F. Rajabli, Seixas, A. A., Akgun, B., Adams, L. D., Inciute, J., Hamilton, K. L., Whithead, P. G., Konidari, I., Gu, T., Arvizu, J., Golightly, C. G., Starks, T. D., Laux, R., Byrd, G. S., Haines, J. L., Beecham, G. W., Griswold, A. J., Vance, J. M., Cuccaro, M. L., and Pericak-Vance, M. A., African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181., J Alzheimers Dis, vol. 98, no. 1, pp. 221-229, 2024.
A. Mahzarnia, Lutz, M. W., and Badea, A., A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5., J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
S. Hermes, Cady, J., Armentrout, S., O'Connor, J., Holdaway, S. Carlson, Cruchaga, C., Wingo, T., and Greytak, E. McRae, Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores., J Alzheimers Dis, vol. 99, no. 4, pp. 1425-1440, 2024.
I. Frentz, van Arendonk, J., Leeuwis, A. E., Vernooij, M. W., van der Flier, W. M., Bos, D., De Deyn, P. Paul, Wolters, F. J., and M Ikram, A., Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function., J Alzheimers Dis, vol. 97, no. 2, pp. 953-961, 2024.
O. Almkvist, Larsson, M., and Graff, C., Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 2, pp. 587-598, 2024.
C. Marr, McDowell, B., Holmes, C., Edwards, C. J., Cardwell, C., McHenry, M., Meenagh, G., Teeling, J. L., and McGuinness, B., The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug., J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.
Y. Shin Park, Joo, H. Jin, Jang, Y. Seo, Jeon, H., Park, E. - C., and Shin, J., Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea., J Alzheimers Dis, vol. 97, no. 1, pp. 273-281, 2024.